The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.

The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).

The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.

The Josep Carreras Leukemia Research Institute Can Ruti We are looking for a Laboratory Technician for the Lymphocyte development and disease group led by Dr. Maribel Parra Bola. This position is funded by the project PID2024-160270OB-I00 financed by MICIU/AEI/10.13039/501100011033/ FEDER, UE.

RESEARCH DESCRIPTION

B-cell lymphopoiesis is a complex developmental process that involves several cellular transitions, including cell commitment and early and late cellular differentiation. Proper transcriptional control at each cellular transition is essential for the correct development of B lymphocytes. How specific gene expression programmes are selected and maintained, thus resulting in the proper generation of B cells, remains a fundamental question in biology. Conversely, how the aberrant establishment of cell- and lineage-specific gene transcriptional programmes leads to the development of B-cell malignancies such as leukaemia and lymphoma also requires extensive research.

MAIN RESPONSABILITIES

• Provide technical support for a project focused on the role of HDAC7 in diffuse large B-cell lymphoma.
• Experiment in mouse models of lymphoma.
• Recombinant DNA techniques, cloning, qRT-PCR.
• Western blot, immunoprecipitation.
• Cell culture of primary and established cell lines.
• FACS and cell cycle analysis.
• ChIP-seq and RNA-seq preparation.
• Immunofluorescence.
• Oversee laboratory stock and order management.

WHAT WE NEED

• Degree in Biology, Genetics or a related field (e.g. Biomedicine, Biomedical Sciences).
• Accredited in laboratory animal experimentation.
• A passion for science and commitment to scientific rigor.
• Interest in research and collaborative team science.
• Excellent communication skills and motivation to contribute to high impact research.
• Proficient in writing and speaking in English.
• Proactivity, initiative and solving problem’s ability.
• Attention to detail and ability to think strategically.
• Leadership and teamworking.
• Ability to work independently and efficiently.
• Organized, self-motivated, and enthusiastic.
• Motivation to perform high quality work.

WHAT WE OFFER

• Contract (Indefinido por actividades científico-técnicas) This position is funded by the project PID2024-160270OB-I00 financed by MICIU/AEI/10.13039/501100011033/ FEDER, UE.
• Full time contract (39 hours per week)
• Training and development opportunities.
• Incorporation in a multinational and highly collaborative team.
• International network of the Institute.
• The stimulating environment of the Barcelona metropolitan area.
• Working in the mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.
• Competitive Salary to be further defined depending on candidate experience.
• The stimulating environment of the IJC and its scientific network.

DEADLINE

Please submit your application by the 23th of December 2025

WHO WE ARE?

What makes us different?

The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.

HR Excellence

In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start-up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.

The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.